Pharmacological treatments of neuropathic pain: The latest recommendations

We provide an up-to-date review of the pharmacological treatment of neuropathic pain with emphasis on the latest evidence-based recommendations for its pharmacological treatment. Drugs proposed as first line include tricyclic antidepressants (particularly amitriptyline), serotonin–norepinephrine reu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revue neurologique Jg. 175; H. 1-2; S. 46 - 50
1. Verfasser: Attal, N.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: France Elsevier Masson SAS 01.01.2019
Elsevier Masson
Schlagworte:
Life Sciences
Neuropathic pain
Personalized medicine
Pharmacotherapy
Recommendations
Recommendations
Pharmacotherapy
Personalized medicine
Neuropathic pain
ISSN:0035-3787
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:We provide an up-to-date review of the pharmacological treatment of neuropathic pain with emphasis on the latest evidence-based recommendations for its pharmacological treatment. Drugs proposed as first line include tricyclic antidepressants (particularly amitriptyline), serotonin–norepinephrine reuptake inhibitors (particularly duloxetine), pregabalin and gabapentin. Second line treatments include lidocaine plasters and capsaicin high concentration patches for peripheral neuropathic pain only, and tramadol. Third line treatments include strong opioids and botulinum toxin A (for peripheral neuropathic pain). Perspectives include the development of new compounds and a more personalized therapeutic approach, which is made possible by recent progress in the assessment and understanding of neuropathic pain.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0035-3787
DOI:10.1016/j.neurol.2018.08.005